Highlights from the American Heart Association 72nd Scientific Sessions: November 6 to 10, 1999

American Heart Journal

Volumn 139, Issue 2, 2000, Pages 359-370

  McGuire, Darren K ^a   Hudson, Michael P ^a   East, Mark A ^a   Dyke, Christopher K ^a   Cantor, Warren J ^a   Battle, Judy ^a   Bahit, M Cecilia ^a   Al Khatib, Sana M ^a   Alexander, John H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CLINICAL EDUCATION; CONFERENCE PAPER; CONTINUING EDUCATION; HUMAN; MEDICAL SOCIETY; POSTGRADUATE EDUCATION; PRIORITY JOURNAL;

EID: 0033983462     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90247-3     Document Type: Conference Paper

References (2)

1. O'Neill WW. The evaluation of xemilofiban in controlling thrombotic events (EXCITE) trial: 30-day and six-month results. Presented at the 48th Scientific Sessions of the American College of Cardiology, New Orleans, Louisiana, March 7 to 10, 1999.
2. Cannon CP. Orbofiban in patients wilh unstable coronary syndromes (TIMI-16) preliminary results. Presented at the 48th Scientific Sessions of the American College of Cardiology, New Orleans, Louisiana, March 7 to 10, 1999.